Horizon Cancer Center Results That Re ect Comprehensive Care The Bumrungrad Horizon Cancer Center is dedicated to personalized cancer care, delivered by a multidisciplinary team of specialists. Combining advanced technology and AI, the center ensures precise and safe treatment outcomes that meet global standards.
Proven Results:
0.49 % Venous thromboembolism (VTE) within 1 year of diagnosis (International standard: 2.3%)
01
30-day post-treatment mortality:
0 % (international standard: 2%)
02
03
1.52 % (international standard: 3.5%) Severe immune-related adverse events within 2 years:
(International standard: 0.09%) 0.018 % Chemotherapy drug leakage outside the patient’s vein
Learn More CLICK
Powered by FlippingBook